section name header

Y-Site Injection Compatibility (1:1 Mixture)

Blinatumomab

(Mfr: AMG)(Conc: 0.125 mcg/mLb)

I

Dexamethasone sodium phosphate

(Mfr: MYL)(Conc: 0.19 mg/mLb)

Remarks:

Persistent particulate formation

Ref:

3405,3417